Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain, announces ...

Nexalin Technology (NXL) has received Institutional Review Board – IRB – approval from the University of California, San Diego, or UCSD, for ...

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency ...

"We are honored to be named Industry Co-Chair of the National TBI Registry Coalition," said Mark White, CEO of Nexalin. "This ...

Nexalin Technology (NXL) announces its appointment as Industry Co-Chair of the National Traumatic Brain Injury Registry Coalition. This ...

The $BHAD token is a fun and dynamic way to show support for Bhad Bhabie and the culture she represents. It captures the ...

Nexalin Technology , Inc. (NASDAQ:NXL), a Delaware-based company specializing in electromedical and electrotherapeutic apparatus, has made a significant step forward with the effectiveness of a ...

Officer and Director at Nexalin Technology , Inc. (NASDAQ:NXL), recently acquired 1,000 shares of the company's common stock. The purchase, which took place on February 4, 2025, was executed at a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

David Owens, the Chief Medical (TASE:PMCN) Officer of Nexalin Technology , Inc. (NASDAQ:NXL), has purchased 1,500 shares of the company's common stock, according to a recent SEC filing.